Pediatric oncology is the branch of medicine focused on diagnosing and treating cancer in children and adolescents, typically those under 17 years of age. It spans everything from the initial blood test that raises concern to years of follow-up care after treatment ends. The field exists as its own specialty because childhood cancers behave fundamentally differently from adult cancers and require distinct expertise.
Why Childhood Cancer Is Its Own Specialty
Most adult cancers develop from decades of accumulated genetic damage, driven by factors like smoking, sun exposure, or aging. Childhood cancers don’t follow that pattern. They arise from different biological mechanisms, often involving developmental pathways that went wrong during the rapid growth of fetal or early childhood tissue. This distinction matters because it means the tumors themselves have different genetics, grow in different locations, and respond to treatment differently than adult cancers do.
The most common cancers in children and adolescents are leukemias (cancers of the blood and bone marrow), brain and central nervous system tumors, and lymphomas (cancers of the immune system). After those, soft tissue tumors, bone tumors, and germ cell tumors round out the list. Adults, by contrast, are far more likely to develop cancers of the breast, lung, colon, or prostate. There is very little overlap between the two populations.
How Childhood Cancer Is Diagnosed
Diagnosing cancer in a child usually involves a combination of imaging, blood work, and tissue sampling. Imaging tests like CT scans, MRIs, ultrasounds, and PET scans help locate tumors and determine their size. Blood tests can reveal abnormal cell counts or markers that suggest certain cancers, particularly leukemia.
Two procedures are especially common in pediatric oncology. A bone marrow aspiration or biopsy involves inserting a hollow needle into a bone, often a hip bone, to collect a sample of marrow for examination under a microscope. A lumbar puncture (spinal tap) involves inserting a small needle between the spinal bones to withdraw cerebrospinal fluid, which is then tested for the presence of cancer cells. Both are routine and typically done under sedation in children to minimize discomfort.
Treatment Approaches
The core treatments in pediatric oncology have been surgery, chemotherapy, radiation therapy, and, for certain cancers, stem cell transplantation. These are often used in combination. A child with a solid tumor might have surgery to remove it, followed by chemotherapy to eliminate any remaining cancer cells. A child with leukemia might receive months of chemotherapy delivered through a vein, with some drugs given directly into the spinal fluid to reach cancer cells in the central nervous system.
Chemotherapy in children typically involves multiple drugs used together, a strategy designed to attack cancer cells through different mechanisms and reduce the chance that the cancer becomes resistant to any single drug. Radiation therapy delivers targeted energy to a specific area of the body, often using external beam machines. Proton beam therapy, a newer form of radiation, is increasingly used in children because it can target tumors more precisely while sparing surrounding healthy tissue, which is especially important in a growing body.
Immunotherapy is a newer and rapidly expanding area of pediatric oncology. Some immunotherapies work by blocking signals that cancer cells use to hide from the immune system, essentially unmasking the tumor so the body’s own defenses can attack it. Others are engineered to recognize specific markers on the surface of cancer cells. One example already in standard use targets a marker found on high-risk neuroblastoma cells, and it has become part of the routine treatment plan for that cancer alongside chemotherapy, radiation, and stem cell transplant.
The Care Team
Pediatric oncology is intensely team-based. At the center is the pediatric oncologist, the physician who directs and manages a child’s cancer treatment. Surrounding them is a wide network: nurses who administer chemotherapy and monitor daily needs, nurse practitioners who perform exams and adjust treatment plans, radiation oncologists who plan and deliver radiation therapy, and surgical oncologists or surgical specialists (such as neurosurgeons for brain tumors or orthopedic surgeons for bone tumors) who perform procedures.
Beyond the physicians and nurses, the team often includes radiologists who interpret imaging, infectious disease specialists who manage the infections that commonly arise when treatment weakens the immune system, rehabilitation specialists in physical therapy, occupational therapy, speech therapy, and audiology, as well as clinical nutritionists who help children maintain healthy eating during treatment. This breadth of support reflects the reality that treating cancer in a growing child affects nearly every system in the body.
How Care Is Standardized
One distinctive feature of pediatric oncology is its high degree of coordination across hospitals. The Children’s Oncology Group (COG) is the world’s largest research organization dedicated exclusively to childhood and adolescent cancer. As of 2016, it included 223 member institutions across seven countries. COG develops standardized treatment protocols that member hospitals follow, which means a child diagnosed with a specific cancer at one hospital is likely to receive the same evidence-based treatment plan as a child diagnosed at another hospital across the country. This structure also makes it easier to enroll children in clinical trials, which have historically played a major role in improving outcomes.
Survival Rates and Progress
Survival rates for childhood cancer have improved dramatically over the past several decades. In the 1970s, fewer than half of children diagnosed with cancer survived. Today, more than 80% of children with cancer will survive five years or more, though the rate varies significantly depending on the type of cancer. Acute lymphoblastic leukemia, the most common childhood cancer, now has a five-year survival rate above 90%. Brain tumors and certain rare cancers still carry lower survival rates, and these remain a major focus of ongoing treatment development.
Late Effects of Treatment
Because so many children now survive cancer, the field has increasingly focused on what happens after treatment ends. Late effects are health problems that emerge months or years after therapy is complete, and they can affect virtually any organ system. The treatments that save a child’s life can leave lasting marks on a body that was still developing when it received them.
Heart-related late effects include weakened heart muscle, abnormal heart rhythms, high blood pressure, and increased risk of blood clots or stroke. Lung problems can range from chronic cough and asthma to scarring of lung tissue. The endocrine system is frequently affected: thyroid disorders are common, and growth hormone deficiency can result in shorter adult height. Bone and joint problems include curvature of the spine and osteoporosis, a condition where bones become thin and fragile.
Fertility is another significant concern. Boys may experience low sperm counts or low testosterone, while girls may face early menopause, irregular periods, or infertility. Hearing loss, vision problems including cataracts and glaucoma, dental decay, kidney issues, and digestive tract complications are all documented late effects. Mental health is also affected: survivors of childhood cancer have higher rates of depression, anxiety, and post-traumatic stress disorder compared to the general population.
Because of these wide-ranging risks, long-term survivorship care is now considered an essential part of pediatric oncology. Many cancer centers run dedicated survivorship clinics where former patients receive ongoing monitoring tailored to the specific treatments they received, sometimes continuing well into adulthood.